Page 2 - விடாமுயற்சி சந்தை ஆராய்ச்சி உலகளாவிய படிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Next-generation antibody-based therapeutics enhances existing properties of therapeutic antibodies for the treatment of various medical conditions such as cancer, infectious diseases, and autoimmune diseases. Globally, the next-generation antibody therapeutics market is witnessing significant growth due to technological advancements in antibody therapeutics and increasing the prevalence of chronic diseases. In addition, rising healthcare expenditure and growing R & D activities are driving the growth of the next-generation antibody therapeutics market. However, stringent regulatory requirements and long approval time for new drug restrains the growth of the market. Similarly, high costs of next-generation antibody therapeutics is a major concern for the market. North America is the largest market for next-generation antibody therapeutics. This is mainly due to increasing prevalence of chronic diseases and increasing healthcare spending in the region. The North America next-generat

United statesKyowa hakko kirin co ltdRoche ltdBayer agXencor incSeattle genetics incPersistence market researchPersistence market research global studyAmgen incImmunogen incMarket studyNext generation antibody therapeuticsBiosimilar antibody productsWitness highest growthSample copyFull report